Sharechat Logo

BUDGET Improved write-offs for R and D spending to proceed

Thursday 15th May 2014

Text too small?

The government is to proceed with new a regime allowing start-up companies to cash out all or part of their tax losses from research and development expenditure, and to write off "black hole" R&D spending on unsuccessful projects.

The announcements are expected to cost the government around $58.1 million over four years and follow a consultation process in which both initiatives were canvassed with the tax and business communities.

"R&D-intensive start-up companies will have early access to all or part their tax losses in the form of a cash receipt, rather than carrying those losses forward," said the Science and Innovation and Revenue Ministers, Steven Joyce and Todd McClay in today's announcements.

In addition, "all capitalised costs on depreciable, intangible assets (for example, patents) will be deductible over time" instead of allowing only the legal and administrative costs of registering the asset to be depreciable.

A one-off deduction will also be allowed for "black hole" expenditure on intangible assets created in unsuccessful projects.

This change would "ensure businesses are not discouraged from undertaking R&D expenditure by start-up companies will assist in reducing constraints on their cashflow and capital."

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors